SCHEMBL1328753

SCHEMBL1328753

CN(C)C(c1ccccc1)C1CCC(NC(=O)c2cccc(C#N)c2)CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADRA2A P08913 1/20 0.56
MCHR1 Q99705 1/20 0.56
MAPK14 Q16539 1/20 0.48
GRM5 P41594 2/20 0.48
NPC1 O15118 3/20 0.47
GPR139 Q6DWJ6 1/20 0.47
ACKR3 P25106 1/20 0.47
S1PR3 Q99500 2/20 0.44
ADRB2 P07550 1/20 0.43
RAB9A P51151 2/20 0.43
ALDH1A1 P00352 2/20 0.43
KDM4E B2RXH2 1/20 0.43
GFER P55789 1/20 0.43
SMN1; SMN2 Q16637 1/20 0.43
HSD17B10 Q99714 1/20 0.43
PKM P14618 1/20 0.43
BRD4 O60885 1/20 0.42
L3MBTL1 Q9Y468 1/20 0.42
SMYD3 Q9H7B4 1/20 0.41
MEN1 O00255 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2307354 0.85 MEN1 (0.52) NPC1ADRB2RAB9AKDM4EGFER
SCHEMBL1326761 0.85 GPR139 (0.50) ADRA2AMCHR1GPR139S1PR3ALDH1A1
Hydrochloric Acid SCHEMBL1327103 0.84 MEN1 (0.51) NPC1ADRB2RAB9AKDM4EGFER
SCHEMBL1326805 0.84 ADRA2A (0.49) ADRA2AMCHR1MAPK14GRM5NPC1
SCHEMBL1327554 0.84 ADRA2A (0.54) ADRA2AMCHR1NPC1ADRB2RAB9A
SCHEMBL1327436 0.84 L3MBTL1 (0.58) ADRA2AMCHR1GRM5NPC1RAB9A
SCHEMBL1327131 0.81 MEN1 (0.56) ADRA2AMCHR1NPC1GPR139ADRB2
SCHEMBL1326826 0.80 ADRA2A (0.57) ADRA2AMCHR1NPC1ALDH1A1SMN1; SMN2
SCHEMBL1327152 0.80 ADRA2A (0.54) ADRA2AMCHR1NPC1GPR139S1PR3
SCHEMBL1326521 0.79 NPC1 (0.53) ADRA2AMCHR1NPC1S1PR3RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8058475-B2 Substituted cyclohexylmethyl compounds GRUENENTHAL GMBH (DE) 2011-11-15 US claimed
EP-1989174-B1 SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES GRUENENTHAL GMBH (DE) 2011-08-03 EP claimed
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds GRUENENTHAL GMBH (DE) 2009-11-19 US claimed
JP-2009520720-A 2009-05-28 JP claimed
EP-1989174-A1 SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES Grünenthal GmbH (DE) 2008-11-12 EP claimed
WO-2007079930-A1 SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES Grünenthal GmbH (DE) 2007-07-19 WO claimed
US-8058475-B2 Substituted cyclohexylmethyl compounds GRUENENTHAL GMBH (DE) 2011-11-15 US disclosed
EP-1989174-B1 SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES GRUENENTHAL GMBH (DE) 2011-08-03 EP disclosed
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds GRUENENTHAL GMBH (DE) 2009-11-19 US disclosed
EP-1989174-A1 SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES Grünenthal GmbH (DE) 2008-11-12 EP disclosed
WO-2007079930-A1 SUBSTITUTED CYCLOHEXYLMETHYL DERIVATIVES Grünenthal GmbH (DE) 2007-07-19 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090286833-A1 Substituted Cyclohexylmethyl Compounds CNR1, H4C1; H4C2; H4C3; H4C4; H4C5; H4C6; H4C8; H4C9; H4C11; H4C12; H4C13; H4C14; H4C15; H4C16, C1R ADRA2A 70/4885MCHR1 429/4885MAPK14 4651/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.